emerging technologies

Connor Glass, founder and CEO of Phantom Neuro, explains how the company's muscle-machine interface for amputees is enabling the development of advanced prosthetic limbs designed to function as natural extensions of the human body.

Julien Payen, cofounder and CEO of Lattice Medical, discusses the company’s 3D-printed breast implant that supports women recovering from mastectomy using a scaffold that gradually dissolves as the patient’s own tissue regenerates.

Anne Osdoit, CEO of Moon Surgical, says the company’s robotic surgery offering serves as a surgical assistant in laparoscopic soft tissue procedures, using robotic arms to hold instruments and AI to give insights into workflow efficiency.

Nissan Elimelech, founder of Augmedics, shares how the company's augmented reality surgical technology projects an anatomically accurate 3D spine onto the patient, helping surgeons operate with their eyes on the body instead of a screen.  

Paul Grand, CEO of MedTech Innovator, discusses how the accelerator embraces high-risk, high-reward technologies and steers them to market with industry expertise.

Alexandre Momeni, a partner at General Catalyst, describes how the VC firm funds visionary founders building frontier technologies while balancing high-risk bets with responsible innovation and strategic portfolio construction.

Morgan Cheatham, partner and head of healthcare and life sciences at Breyer Capital, provides highlights of the venture capital firm's strategy when funding emerging technologies and the risks associated with backing these innovations.

Jayme Strauss, Precision Neuroscience's chief clinical and commercial officer, kicks off the Emerging Technologies series, discussing how the company's brain-computer interface, Layer 7, works and what it hopes to accomplish for patients.